Physician profile
Anna Thompson
NPI 1568217073
$1,030.60
in general payments reported to CMS, 2019-2025
11 companies · $902 in 2025
The $902 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $128 · 2025: $902.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,031.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,030.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $389.68 | 2025 | Inceptiv |
| Si-Bone, INC. | $216.02 | 2025 | |
| Boston Scientific Corporation | $141.74 | 2025 | Intracept, Ams 700 |
| Dendreon Pharmaceuticals LLC | $53.50 | 2024 | Provenge |
| Procept Biorobotics Corporation | $51.05 | 2025 | |
| Merck Sharp & Dohme LLC | $50.86 | 2024 | Welireg, Keytruda, Lynparza |
| Vertex Pharmaceuticals Incorporated | $44.25 | 2025 | |
| Orthofix Medical, INC. | $30.72 | 2025 | Physio-Stim |
| Abbvie INC. | $23.93 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.79 | 2025 | Relistor |
| Verity Pharmaceuticals INC. | $14.06 | 2025 | Trelstar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.